Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR. JANUMET® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
JANUMET® XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use JANUMET XR should not be used in patients with type 1 diabetes mellitus.JANUMET XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using JANUMET XR [see Warnings and Precautions (5.2)].
- generic_name
- sitagliptin and metformin hydrochloride
- product_names
- sitagliptin and metformin hydrochloride
- ndc
- 0006-0078, 0006-0078-61, 0006-0078-62, 0006-0078-82, 0006-0078-14, 0006-0078-28, 0006-0080, 0006-0080-61, 0006-0080-62, 0006-0080-82, 0006-0080-14, 0006-0080-28, 0006-0081, 0006-0081-31, 0006-0081-54, 0006-0081-82, 0006-0081-07, 0006-0081-14
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en